The
dangers of bextra were
officially spelled out on www.bextra.com during the first week
of April, when this Pfizer website announced that the U.S. Food
and Drug Administration had demanded the suspension of Bextra
sales due to the dangers of bextra and its cardiovascular and
gastrointestinal risks. Bextra, and other prescription
non-steroidal anti-inflammatory arthritis medicines are
attributed to an increased risk of hazardous cardiovascular and
circulation problems including strokes and heart attacks. As
well as rare and potentially fatal reactions to the skin,
specifically the life threatening disease of the skin known as
Stevens-Johnson Syndrome. The website gives more information on
the dangers of bextra recall
and bextra side effects, you can do a Google search or type in
Bextra on Ask Jeeves and you will find out what you need to
know.
Bextra was considered to be a commonly used drug in the
successful treatment and pain control of arthritis and its
symptoms like inflammation. Belonging to the class of
pharmaceutical drugs called ‘COX-2 Inhibitors’, the dangers of
bextra came to the forefront following the Vioxx recall in
September of last year, when further research showed that the
same, serious problems associated with Vioxx could be found with
Bextra.
Other world health organizations in North America including
Health Canada, and medical organizations across Europe also
called for Pfizer to halt Bextra sales, so the drug cannot be
purchased from any pharmacy, hospital or medical clinic across
North America and Europe.
An American Health Association further report determined the
dangers of bextra, stating
that patients on Bextra suffered twice as many strokes and heart
attacks than people given a placebo drug. Findings were made
based on data culled from twelve unassociated studies in a
clinical setting. Pfizer has apparently tried to refute the
dangers of bextra, using their own statistics from a clinical
trial that found Bextra to be a non-factor in heart attacks and
strokes. But it was discovered that this study monitored users
of the drug for under a year, whereas it is now medically
believed that the increased health risks become apparent after
more than a year of usage, taking patients more than 18 months
to truly discover the dangers of bextra. |